Cardinal Health, Inc. (CAH)
NYSE$130.03
Market Cap
$31.41B
Sector
Healthcare
Industry
Medical—Distribution
Rank in Sector
500 of 924
Rank in Industry
5 of 9
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
CAH Insider Trading Activity
CAH Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | 0 |
Sells | $22,078,021 | 10 | 100 |
Related Transactions
| Alt Aaron E | Chief Financial Officer | 0 | $0 | 1 | $252,998 | $-252,998 |
| Scherer Mary C. | Chief Accounting Officer | 0 | $0 | 1 | $432,919 | $-432,919 |
| Greene Michelle D. | Chief Information Officer | 0 | $0 | 1 | $435,400 | $-435,400 |
| Mayer Jessica L | Chief Legal/Compliance Officer | 0 | $0 | 2 | $3.72M | $-3.72M |
| Snow Ola M | Chief Human Resources Officer | 0 | $0 | 2 | $4.13M | $-4.13M |
| Mason Stephen M | CEO, GMPD Segment | 0 | $0 | 1 | $5.13M | $-5.13M |
| Hollar Jason M. | Chief Executive Officer | 0 | $0 | 2 | $7.97M | $-7.97M |
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer …
Insider Activity of Cardinal Health, Inc.
Over the last 12 months, insiders at Cardinal Health, Inc. have bought $0 and sold $22.08M worth of Cardinal Health, Inc. stock.
On average, over the past 5 years, insiders at Cardinal Health, Inc. have bought $29,239 and sold $9.02M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $14,944 was made by Brennan Michelle (director) on 2022‑11‑15.
List of Insider Buy and Sell Transactions, Cardinal Health, Inc.
| 2024-11-14 | Sale | Scherer Mary C. | Chief Accounting Officer | 3,504 0.0015% | $123.55 | $432,919 | +2.82% | |
| 2024-08-21 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 16,573 0.0068% | $109.39 | $1.81M | +9.16% | |
| 2024-08-19 | Sale | Hollar Jason M. | Chief Executive Officer | 46,455 0.0189% | $109.02 | $5.06M | +8.73% | |
| 2024-08-19 | Sale | Mason Stephen M | CEO, GMPD Segment | 46,998 0.0192% | $109.21 | $5.13M | +8.73% | |
| 2024-08-19 | Sale | Alt Aaron E | Chief Financial Officer | 2,323 0.0009% | $108.91 | $252,998 | +8.73% | |
| 2024-08-19 | Sale | Snow Ola M | Chief Human Resources Officer | 34,647 0.0141% | $109.00 | $3.78M | +8.73% | |
| 2024-08-19 | Sale | Greene Michelle D. | Chief Information Officer | 4,000 0.0016% | $108.85 | $435,400 | +8.73% | |
| 2024-08-16 | Sale | Hollar Jason M. | Chief Executive Officer | 26,716 0.0119% | $108.87 | $2.91M | +8.65% | |
| 2024-08-16 | Sale | Snow Ola M | Chief Human Resources Officer | 3,294 0.0015% | $108.00 | $355,752 | +8.65% | |
| 2024-08-15 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 17,896 0.0078% | $106.48 | $1.91M | +10.57% | |
| 2023-11-27 | Sale | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 36,642 0.0148% | $106.31 | $3.9M | +0.17% | |
| 2023-08-28 | Sale | WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 6,712 0.0027% | $89.81 | $602,805 | +15.39% | |
| 2023-08-18 | Sale | Scherer Mary C. | Chief Accounting Officer | 20,695 0.0082% | $86.27 | $1.79M | +19.62% | |
| 2023-08-17 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 10,668 0.0043% | $87.68 | $935,370 | +18.82% | |
| 2023-08-17 | Sale | Mason Stephen M | CEO, Medical Segment | 37,500 0.0149% | $87.32 | $3.27M | +18.82% | |
| 2023-08-17 | Sale | Snow Ola M | Chief Human Resources Officer | 26,324 0.0105% | $87.41 | $2.3M | +18.82% | |
| 2023-08-17 | Sale | Greene Michelle D. | Chief Information Officer | 2,000 0.0008% | $86.79 | $173,580 | +18.82% | |
| 2023-08-16 | Sale | Mayer Jessica L | Chief Legal/Compliance Officer | 30,145 0.0119% | $90.84 | $2.74M | +13.47% | |
| 2022-11-15 | Brennan Michelle | director | 200 <0.0001% | $74.72 | $14,944 | +15.31% | ||
| 2022-11-14 | Brennan Michelle | director | 200 <0.0001% | $76.30 | $15,260 | +13.62% |
Total: 230
*Gray background shows transactions not older than one year
Insider Historical Profitability
6.05%
| Snow Ola M | Chief Human Resources Officer | 27516 0.0114% | $3.58M | 2 | 5 | +14.82% |
| WALTER ROBERT D | director | 937754 0.3882% | $121.94M | 1 | 12 | +9.11% |
| CLARK R KERRY | Former Chairman and CEO | 172680 0.0715% | $22.45M | 1 | 0 | <0.0001% |
| FORD BRENDAN A | EVP-Corporate Development | 87052 0.036% | $11.32M | 1 | 4 | +25.2% |
| FOTIADES GEORGE L | President & COO | 80400 0.0333% | $10.45M | 6 | 2 | <0.0001% |
*Gray background shows insiders who have made transactions during last year
CAH Institutional Investors: Active Positions
| Increased Positions | 550 | +49.15% | 21M | +9.91% |
| Decreased Positions | 475 | -42.45% | 22M | -10.48% |
| New Positions | 172 | New | 6M | New |
| Sold Out Positions | 91 | Sold Out | 5M | Sold Out |
| Total Postitions | 1,194 | +6.7% | 210M | -0.58% |
CAH Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Blackrock, Inc. | $4.12M | 13.3% | 32.2M | +200,852 | +0.63% | 2024-12-31 |
| Vanguard Group Inc | $3.94M | 12.72% | 30.77M | -20,738 | -0.07% | 2024-12-31 |
| State Street Corp | $1.77M | 5.71% | 13.82M | -355,821 | -2.51% | 2024-12-31 |
| Geode Capital Management, Llc | $749,969.00 | 2.42% | 5.86M | +109,273 | +1.9% | 2024-12-31 |
| Morgan Stanley | $650,141.00 | 2.1% | 5.08M | +131,515 | +2.66% | 2024-12-31 |
| Fmr Llc | $538,660.00 | 1.74% | 4.21M | -118,741 | -2.74% | 2024-12-31 |
| Millennium Management Llc | $434,717.00 | 1.4% | 3.4M | +3M | +331.05% | 2024-12-31 |
| Citadel Advisors Llc | $408,762.00 | 1.32% | 3.19M | +2M | +91.98% | 2024-12-31 |
| Invesco Ltd. | $407,362.00 | 1.32% | 3.18M | +140,368 | +4.61% | 2024-12-31 |
| Marshall Wace, Llp | $403,422.00 | 1.3% | 3.15M | +2M | +154.62% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.